ST. LOUIS, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced that its Board of Directors ...
The page may have been moved or deleted. You can try searching for it below, move on or ask for help.
NextEra Energy Partners, LP (NYSE: NEP) today announced the company is changing its name to XPLR Infrastructure, LP, effective today, and will begin trading under the new ticker symbol, XIFR, on the ...
NextEra Energy Partners said it was changing its name to XPLR Infrastructure, effective Thursday. The clean-energy company also said it would begin trading under a new symbol, XIFR, on the New York ...
Lithium Argentina AG (formerly Lithium Americas (Argentina) Corp.) (“Lithium Argentina” or the “Company”) (TSX: LAAC) (NYSE: LAAC) announces that it has completed the previously announced plan to ...
American Axle & Manufacturing (NYSE:AXL) has announced a $1.44 billion cash and stock merger pact with Dowlais Group. The combination will create a leading global driveline and metal forming supplier ...
Blank check company Soulpower Acquisition filed for a $200 million initial public offering Friday. The company said its chairman and chief executive, Justin Lafazan, founded Next Gen HQ in 2014. He ...
Focus Universal inc. (Nasdaq:FCUV) (”Focus” or the “Company”), a provider of patented hardware and software design technologies for Internet of Things (IoT) and 5G, announces that its board of ...
Since IPO, Disney stock has been traded on the New York Stock Exchange under the ticker symbol DIS, it has been one of the 30 stocks in the Dow Jones industrial average since 1991. Disney’s ...
A definitive prospectus has now been filed with the SEC for the Brookmont Catastrophic Bond ETF, a new exchange traded fund strategy that will be ...
Ally Financial (NYSE:ALLY), formerly known as GMAC Inc., is a major player in the finance sector, offering a range of financial products and services. With a market capitalization of nearly $12 ...
Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a multi-asset, clinical stage, disease-agnostic life science company delivering an efficient model for compound development, ...